Quantum Genomics and Biolab Sanus Pharmaceutical have signed an exclusive agreement for firibastat in Latin America (My Pharma Edition – French only)

https://www.mypharma-editions.com/quantum-genomics-et-biolab-sanus-pharmaceutical-concluent-un-accord-exclusif-de-licence-et-de-collaboration-pour-firibastat-en-amerique-latine

https://www.mypharma-editions.com/quantum-genomics-et-biolab-sanus-pharmaceutical-concluent-un-accord-exclusif-de-licence-et-de-collaboration-pour-firibastat-en-amerique-latine